Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction

Clinical trial NCT02801357 · COMPLETED

Trial details

NCT number: NCT02801357
Sponsor: USWM, LLC (dba US WorldMeds)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Substance Withdrawal Syndrome Opiate Addiction Opiate Dependence

Start date: 2016-06-01
Primary completion: 2016-08-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.